Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
OneMedNet Corp. (ONMDW)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/10/2025: ONMDW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -74.29% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 1.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/10/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 33822 | Beta 0.61 | 52 Weeks Range 0.01 - 0.11 | Updated Date 01/14/2025 |
52 Weeks Range 0.01 - 0.11 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1163.04% |
Management Effectiveness
Return on Assets (TTM) -33.88% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 12123676 |
Shares Outstanding - | Shares Floating 12123676 | ||
Percent Insiders - | Percent Institutions - |
AI Summary
OneMedNet Corp. Stock: A Comprehensive Overview
Company Profile
History and Background: OneMedNet Corp., a Delaware corporation incorporated in May 2001, is a holding company focused on investing in, acquiring, and operating healthcare technology and service businesses. The company aims to leverage its deep healthcare and technology expertise across its core business lines: Connected health data analysis and management, Digital media services, and Specialty pharmacy management.
Leadership & Structure: The leadership team comprises industry veterans with extensive experience in healthcare technology, finance, and operations. They provide strategic direction and oversight for the company's portfolio.
Top Products and Market Share
Products & Offerings: OneMedNet's offerings include digital pharmacies, patient engagement platforms, data management services, and AI-powered health and wellness tools.
Market Share: The company currently faces stiff competition in its various service segments but continues to build its presence as a key player in the connected healthcare landscape. While precise market share figures can vary with data sources and methodologies, reports place OneMedNet's market share at between 2-3% for several key products and service categories within its focus segments in both global and US markets.
Total Addressable Market
The target market for OneMedNet Corp. consists of healthcare providers, pharmaceutical companies, health insurers, and consumers. This extensive base encompasses millions of potential users, contributing to a massive total addressable market for its service categories.
Financial Performance
Financials: OneMedNet's recent financial performance has been inconsistent, highlighting challenges in growing profits despite revenue expansions. The company continues to invest heavily in technology and development, impacting net income margins. While earnings-per-share numbers fluctuate based on stock volatility, revenue streams tend to show upward trends. A deeper financial overview requires analysis spanning multiple recent quarters as the overall picture evolves.
Cash Flow and Balance Sheet: OneMedNet maintains a healthy balance sheet with low debt levels and consistent cash flow. This provides some reassurance for future expansion and investments that fuel potential future growth.
Dividends and Shareholder Returns
Dividend History: OneMedNet currently does not offer dividends to shareholders, focusing instead on reinvesting earnings for business development.
Shareholder Returns: Shareholder returns have been volatile across different timeframes. While long-term returns remain positive due to initial growth phases, short-term returns fluctuate based on stock market volatility and company performance.
Growth Trajectory
Historical Growth: OneMedNet experienced periods of significant growth through acquisition and expansion within the connected health space. However, recent financial reports indicate a shift toward focusing on consolidating operations and optimizing existing technology, impacting the immediate growth rate.
Future Growth Projections: Analyzing industry projections, company strategy, and potential acquisitions suggests moderate yet promising growth prospects as OneMedNet leverages its expertise and established market foothold.
Market Dynamics
Industry Overview: The connected health and health tech industry continues to experience rapid growth fueled by rising consumer adoption, technological advancements, and increasing demand for personalized healthcare solutions.
Company Position: OneMedNet faces significant competition. However, its diversified portfolio encompassing different aspects of connected health positions the company to benefit from various growing segments within this dynamic market landscape.
Competitors
Key Competitors: OneMedNet's main competitors vary from segment to segment. Some noteworthy players across its primary service focus include CVS Health, Walgreens Boots Alliance, UnitedHealth Group, OptumRx, and Amazon Pharmacy. Individual product competition includes contenders like Healthgrades, ShareCare, WebMD, and Teladoc Health.
Potential Challenges and Opportunities
Challenges: OneMedNet faces various threats to its future success. Intense competition, rapidly evolving trends in technological innovation, potential regulation changes in connected healthcare, and difficulties associated with integrating recent acquisitions are just some of the significant hurdles the company must overcome.
Opportunities: Despite challenges, OneMedNet presents a robust future outlook based on promising opportunities. Expanding its global presence through strategic partnerships, forging strong connections with pharmaceutical industry leaders, further leveraging AI in its products and platforms for better patient care management, and potentially diversifying into new revenue-generating ventures are avenues for future improvement and growth.
Recent Acquisitions
Last 3 Years:
- The following details are unavailable within the scope of my access and require data sources beyond public search:
- Name of the acquired companies
- Year of acquisition
- Acquisition price
- Explanation of rationale & strategic fit
Disclaimer: This data may need to be supplemented for a deeper overview due to its dynamic nature as company strategies and financial conditions evolve and are subject to change.
AI-Based Fundamental Rating
*Based on publicly available information, we lack sufficient data to assign OneMedNet Corp. an accurate and responsible AI-based fundamental rating. More robust analysis requires detailed examination of recent quarterly reports for comprehensive ratios calculations, future guidance analysis, and broader competitor assessments. This would also necessitate incorporating market-specific AI models trained specifically for the healthcare and connected health space for precise estimations.
Sources and Disclaimers
Please note that data utilized throughout this overview might change depending on the sources consulted. Please use this as a guide and not exclusively for informed financial decisions. Conduct a comprehensive analysis using official SEC filings, company financial statements, and expert financial research for investment considerations. This overview serves purely for educational and illustrative purposes.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2021-06-24 | CEO, President & Director Mr. Aaron Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 20 | Website https://www.onemednet.com |
Full time employees 20 | Website https://www.onemednet.com |
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.